ADVANCED PANCREATIC ADENOCARCINOMA
Clinical trials for ADVANCED PANCREATIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PANCREATIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Nanoparticles boost radiation's punch against tough lung and pancreatic tumors
Disease control Recruiting nowThis study combines a special nanoparticle (AGuIX) with precise, MRI-guided radiation to treat hard-to-reach lung tumors and advanced pancreatic cancer. The goal is to see if adding these nanoparticles makes radiation more effective at controlling tumors without increasing side e…
Matched conditions: ADVANCED PANCREATIC ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Could an arthritis drug boost chemo for pancreatic cancer?
Disease control Recruiting nowThis early-stage trial tests whether adding leflunomide (an arthritis drug) to standard chemotherapy (gemcitabine) is safe and effective for people with advanced pancreatic cancer that cannot be removed by surgery. About 19 adults will take part. The goal is to find the best dose…
Matched conditions: ADVANCED PANCREATIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Scientists hunt for hidden subtypes of cancer wasting to personalize treatment
Knowledge-focused Recruiting nowThis study watches 800 people with advanced lung, pancreatic, or colorectal cancer to find different types of cancer-related weight and muscle loss (cachexia). Researchers hope to discover why some patients lose weight differently than others. The goal is to create better, more p…
Matched conditions: ADVANCED PANCREATIC ADENOCARCINOMA
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated May 26, 2026 06:58 UTC